90%!辉瑞的RSV疫苗对严重呼吸系统疾病有显著疗效

生物药大时代
18 Oct 2024

声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。该公司表示,辉瑞的RSV 疫苗在预防有史以来第一个疫苗接种季节最严重后果方面的有效性为 90%,这突显了随着另一个呼吸道病毒季节的开始,它的潜在好处。周四在IDWeek 上公布的新数据更清楚地展示了 Abrysvo 在预防重症和住院治疗方面的表现。结果...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10